For localized information and support, would you like to switch to your country-specific website for {0}?
The benefits of INR self-testing
It is important to keep your blood’s clotting time within the range prescribed by your doctor. You may need to take your anticoagulant for a few weeks, months or even for the rest of your life. But no matter how long, your levels need to be regularly measured and that’s where INR self-testing is a great benefit.
Have the peace of mind that you know your INR value when needed, home or away. Self-monitoring only requires a drop of blood and results are available in about a minute.1 Results can either be reported to your doctor or nurse who will adjust your vitamin K antagonist dose for you, or you can learn how to adjust the dose yourself.

Say yes to more me time. Discover the benefits of INR self-testing.

More freedom
Test your INR anywhere and anytime with immediate results that are comparable to those you would get from the lab2,3
INR self-testing can lead to fewer visits to the laboratory, no waiting for test results, and fewer calls or visits to your doctor for dose adjustment decisions4-6

More control
Gain better control of your anticoagulation therapy. Compared to having your INR values tested in the laboratory or anticoagulation clinic, INR self-testing can lead to:
- More time in your therapeutic range7-9
- Fewer incidents of very high or low INR values10

Better care
Studies show that INR self-testing can lead to:
- Improved health and quality of life6-8,11,12,14,15
- Better treatment satisfaction13-15
Abbreviations
INR: International Normalized Ratio
References
- Roche Diagnostics Ltd. CoaguCheck XS PST Test package insert; V7.1, 2021
- Plesch et al. (2009). Int J Lab Hematol 31, 20–25
- Ryan et al. (2010). Int J Lab Hematol 32, e26–33
- Grunau et al. (2011). Can Fam Physician 57, e292-e298
- Bloomfield et al. (2011). Ann Intern Med 154, 472–482
- Sharma et al. (2015). Health Technol Assess 19, 1–172
- Garcia-Alamino et al. (2010). Cochrane Database Syst Rev 4, CD003839
- Soliman Hamad et al. (2009). Eur J Cardiothorac Surg 35, 265–269
- Siebenhofer et al. (2007). Thromb Haemost 97, 408–416
- Dignan et al. (2013). Int J Cardiol 168, 5378–5384
- Heneghan et al..(2012). Lancet 379, 322–334
- Christensen et al..(2016). Ann Thorac Surg 101, 1494–1499
- Siebenhofer et al. (2012). Thromb Res 130, e60–e66
- Tamayo Aguirre et al. (2016). BMC Cardiovasc Disord 16, 180
- Verret et al. (2012). Pharmacotherapy 32, 871–879